1. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, et al: Excerpts From the United States Renal Data System 2008 Annual Data Report Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Am J Kidney Dis. 2009, 53 (Suppl 1): S47-S64.
2. Covic A, Gusbeth-Tatomir P, Goldsmith DJ: The challenge of cardiovascular risk factors in end-stage renal disease. J Nephrol. 2003, 16 (4): 476-86.
3. Locatelli F, Covic A, Eckardt KU, Andrzej Wiecek, Raymond Vanholder, on behalf of theERA-EDTA ERBP Advisory Board: Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2008, 24 (2): 348-354.
4. Vanholder R, Cornelis R, Dhondt A, Norbert Lameire: The role of trace elements in uraemic toxicity. Nephrol Dial Transplant. 2002, 17 (3): 2-8.
5. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R, Gill J, for the Alberta Kidney Disease Network: Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Medicine. 2009, 7: 25-